University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Impact of Vitamin D Therapies on Chronic Kidney Disease

Not Applicable

Completed

Conditions: Chronic Kidney Disease (CKD)
End-stage Renal Disease (ESRD)

Interventions: Drug: Cholecalciferol - CKD
Device: Calcitriol - CKD
Drug: Cholecalciferol - non-CKD

First Posted Date: 2010-10-18

Last Posted Date: 2016-05-16

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 56

Registration Number: NCT01222234

Locations: 🇺🇸
University Of Kansas Medical Center, Kansas City, Kansas, United States

Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer

Phase 2

Completed

Conditions: Renal Cell Cancer

Interventions: Drug: sorafenib

First Posted Date: 2010-08-26

Last Posted Date: 2017-06-01

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 25

Registration Number: NCT01189370

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Telomere and Telomerase

Withdrawn

Conditions: Acute Myeloid Leukemia

Interventions: Genetic: Blood sample

First Posted Date: 2010-08-06

Last Posted Date: 2017-01-10

Lead Sponsor: University of Kansas Medical Center

Registration Number: NCT01176422

Locations: 🇺🇸
University of Kansas Medical Center, Westwood Campus, Westwood, Kansas, United States

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Early Phase 1

Completed

Conditions: Stem Cell Leukemia of Unclear Lineage
Graft Versus Host Disease

Interventions: Drug: extracorporeal photopheresis

First Posted Date: 2010-08-04

Last Posted Date: 2017-01-09

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 22

Registration Number: NCT01174940

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.

Completed

Conditions: Blood Stem Cell Transplant Failure
Graft Versus Host Disease

Interventions: Other: Collection of blood sample

First Posted Date: 2010-08-03

Last Posted Date: 2017-01-10

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 23

Registration Number: NCT01174277

Locations: 🇺🇸
Children's Mercy Hospital, Kansas City, Missouri, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)

Completed

Conditions: Small Cell Lung Cancer

First Posted Date: 2010-08-02

Last Posted Date: 2017-01-10

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 25

Registration Number: NCT01173458

Locations: 🇺🇸
University of Nebraska & Omaha VA, Omaha, Nebraska, United States
🇺🇸
University of Kansas Medical Centner, Kansas City, Kansas, United States

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

Early Phase 1

Completed

Conditions: Malignant Lymphoma, Stem Cell Type
Autologous Transplant

Interventions: Drug: bortezomib and G-CSF

First Posted Date: 2010-07-28

Last Posted Date: 2017-01-11

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 21

Registration Number: NCT01171092

Locations: 🇺🇸
University of Kansas Medical Center, Westwood Campus, Westwood, Kansas, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

A Research Study Looking at Specific Tissue of the Umbilical Cord

Completed

Conditions: Varices of Umbilical Cord

First Posted Date: 2010-07-21

Last Posted Date: 2016-08-22

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 64

Registration Number: NCT01166776

Locations: 🇺🇸
Children's Mercy Hospital, Kansas City, Missouri, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine

Early Phase 1

Completed

Conditions: Lymphoma

Interventions: Drug: Bendamustine
Drug: Rituximab

First Posted Date: 2009-12-01

Last Posted Date: 2017-01-10

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 17

Registration Number: NCT01022021

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes
Insulin Resistance

Interventions: Behavioral: Exercise

First Posted Date: 2009-09-07

Last Posted Date: 2015-09-24

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 30

Registration Number: NCT00972452

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy